Motilal Oswal has highlighted GE Vernova T&D and Apollo Hospitals for the week of July 13, 2026, citing infrastructure growth and healthcare expansion. Investors should note that these brokerage picks are based on long-term project pipelines and capacity additions. Any investment decisions should consider individual company fundamentals, recent financial results, and broader market volatility.
As the Indian stock market navigates the start of the first-quarter FY27 earnings season, brokerage focus has turned toward companies with visible growth pipelines in the power transmission and healthcare sectors. Motilal Oswal Wealth Management has spotlighted GE Vernova T&D India and Apollo Hospitals, focusing on their strategic expansion plans and market positioning.
GE Vernova T&D India and Power Sector Trends
GE Vernova T&D India operates in a sector currently benefiting from India's energy transition. The company’s performance is closely tied to the modernization of the national power grid and the integration of renewable energy projects. With an order book totaling INR 148 billion in FY26, the company holds a significant pipeline for execution. While the domestic power transmission segment faces periodic adjustments in capacity and project timelines, the company is increasingly looking toward export markets, particularly the United States, to support its revenue streams. Investors should track whether the company can effectively manage potential execution risks and raw material pricing pressures, which often affect margins in the capital-intensive power equipment sector.
Apollo Hospitals Capacity Expansion
Apollo Hospitals is focusing on scaling its integrated healthcare ecosystem, which includes its hospital division, HealthCo, and Apollo Health & Lifestyle. The company has announced a pipeline of over 3,400 new beds, a move intended to capitalize on sustained demand for healthcare services. From a financial perspective, the company’s success in this growth phase will depend on its ability to maintain high occupancy rates and manage the costs associated with new capacity. The hospital sector in India is highly competitive, and while premiumization and digital health initiatives like Apollo 24|7 are expected to support margins, investors should monitor the company’s debt levels as it engages in this large-scale expansion. Any delay in commissioning new beds or a slowdown in the monetization of digital assets could impact return ratios.
Broader Market Context
Market participants are balancing these company-specific narratives against macroeconomic factors as of mid-July 2026. The Indian equity market has seen a recent shift in foreign investor sentiment, with net inflows of over Rs 15,157 crore in July following a period of sustained selling. However, ongoing monitoring of the June CPI and WPI inflation figures, combined with the impact of global geopolitical tensions and crude oil price fluctuations, remains essential. Investors often track these macro indicators to gauge the potential for interest rate changes and their subsequent impact on company borrowing costs. The upcoming management commentaries from the current earnings season will provide the most direct evidence of whether these companies can meet the growth expectations set by analysts.